RenovoRx, Inc.

SEC filing

Biotechnology · Mountain View, CA

Form D on EDGAR

Amount raised$10Msold at filing

Total offering$10M$71 still open

Investors in the raise16count reported to the SEC

FiledApr 9, 2026first sale Mar 20, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Shaun R. BagaiExecutive Officer, Director

Kirsten Angela MacfarlaneDirector

Laurence J. MartonDirector

Leesa R. GentryExecutive Officer

Mark R. VollExecutive Officer

Una S. RyanDirector

Robert J. SpiegelDirector

Ramtin R. AgahExecutive Officer

Executive officers, directors and promoters as listed on the Form D.